Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Laws on the books, gaps in practice. Despite 39 states passing anti-discrimination laws for organ transplants, patients with intellectual and developmental disabilities (IDDs) are still significantly less likely to be evaluated for or receive a kidney transplant. A new JAMA Internal Medicine study found no measurable impact from these laws — and researchers say awareness, legal access, and transparency are key missing pieces.
Thirty-nine U.S. states have enacted laws since 2013 to protect people with disabilities from discrimination in organ transplantation — but a new study published in JAMA Internal Medicine suggests those protections aren't translating into real-world equity. Researchers from Ohio State University analyzed Medicare data from over 61,000 patients and found that people with intellectual and developmental disabilities (IDDs) remain far less likely to be evaluated for or receive a kidney transplant compared to those without IDDs.
The study authors point to several reasons the laws may be falling short: no known legal cases have been brought under these statutes, many patients and families may be unaware of their rights, and navigating the legal system is costly and complex. Researchers are calling for a more transparent, measurable transplant pipeline where every stage — from referral to surgery — is tracked and documented.
By the Numbers
Why it matters: Anti-discrimination laws are only as effective as their enforcement. Without awareness, accountability, and systemic transparency, vulnerable patients continue to fall through the cracks of an otherwise sophisticated transplant system.